Israel Active

Ben Gurion University scientists have just published the results of their work reported in 2019. In trying to develop a biologic remedy to reduce the methane produced by cows, they have uncovered a war in the intestines between good and bad bacteria and a probiotic toxin that tries to mediate.

Researchers at Israel’s Ben Gurion University have developed a nanometer size polymer containing a peptide for delivering chemotherapy. In lab tests, it was over 50% successful in destroying resistant liver metastases (secondary cancer) materialized from colorectal cancer.

A study of 23 progressive multiple sclerosis patients at Hadassah Hospital Ein Kerem highlighted significant beneficial effects of repeated stem cell injections. They improved neurological function, cognition, and quality of life with no adverse effects.

The pain-relieving video games from Israel’s TrainPain (see previously) are now available to download on iPhone and Android phones. You also need to order (fees required) the haptic pod and cables. Available in the US only.

The prestigious Nature magazine named Israeli Tal Patalon, outgoing head of the KSM research and innovation center of Maccabi Healthcare Services, as one of the world’s change-makers in medical research. Her team’s COVID-19 research changed vaccination policies in the United States.

The first European MedEx event took place in Paris, gathering more than 400 doctors and dentists from France and Belgium. At MedEx, potential immigrant medics can convert licenses and engage directly with representatives from Israeli healthcare institutions.  

An interesting article explaining how Israel’s CytoReason (see previously) is using AI and big data from the medical companies themselves to help reduce the cost and time required to bring a new remedy to market.

What seems to be an obvious statement has been proved in a study by Tel Aviv University researchers. They examined over 3,000 heart bypass patients and found that patients who live in a “greener” environment are at a lower risk of mortality than those who live in a “non-green” environment.  

The xBar sensor from Israel’s Exero Medical (see previously) is about to begin a Phase 3 pivotal clinical trial in the USA and Israel. The device aims to immediately detect post-operative leakage following gastro surgery, which is fatal in 40% of affected cases.

Researchers at Tel Aviv University have discovered in the laboratory that two existing medicines can be used to enhance treatments against bone cancer. It is important as bone cancer is often the result of metastasis (spreading) in breast cancer patients.